Motility News

The FDA has granted 510(k) clearance to the EsophyX Z device, which requires fewer steps for transoral incisionless fundoplication procedures to treat gastroesophageal reflux disease, the manufacturer announced.

Only 10% of preterm and term infants with strong clinical suspicion for reflux actually had true GERD based on multichannel intraluminal impedance testing, according to the results of a retrospective study.

BALTIMORE — Children with mild gastroenteritis and minimal dehydration experienced fewer treatment failures when given diluted apple juice followed by their preferred fluids compared with electrolyte maintenance solution, according to new research published in JAMA.

Inulin supplementation increased serum magnesium levels in patients with proton pump inhibitor-induced hypomagnesemia, according to the results of a recent study.

Use of surgical fundoplication in patients with GERD has rapidly declined in the U.S. between 2009 and 2013, according to the results of a national population-based study.

The FDA has accepted the New Drug Application for plecanatide for the treatment of chronic idiopathic constipation, having determined it is “sufficiently complete to permit a substantive review,” the manufacturer announced.

Proton pump inhibitor use was associated with increased risk for incident chronic kidney disease, progression of chronic kidney disease and end-stage renal disease, according to data from a recent study.

Exercise, specifically running, induced changes in healthy individuals that are similar to those observed in patients with GERD, and that exercise-induced reflux episodes are caused almost entirely by transient lower esophageal sphincter relaxations, according to a recent study.

High-resolution manometry was superior to conventional manometry for diagnosing esophageal motility disorders in patients with unexplained dysphagia, according to the results of a randomized trial.

The fourth largest U.S. commercial health insurer, Health Care Service Corporation, has issued a medical coverage policy for the LINX Reflux Management System, an alternative to surgical fundoplication for the treatment of gastroesophageal reflux disease, according to a press release from the manufacturer.